Misako Nagasaka

66PUBLICATIONS
215CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)South-East Asian languages (excl. Indonesian)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (66)

|Jul 01, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II Trial.

|Jun 18, 2026
Real-World Patient Characteristics, Mutational Landscape, and Outcomes in Advanced/Metastatic HER2-Mutant Non-Small Cell Lung Cancer.

|Jun 08, 2026
Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.

|Jun 04, 2026
Sunvozertinib in EGFR Exon 20 Insertion NSCLC: Approved but Not Available - Practical Dose Selection Considerations and Real-World Access Challenges.

|May 20, 2026
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib - A Case Report.

|May 08, 2026
Characterization and clinical management of adverse events following treatment with repotrectinib: a TRIDENT-1 analysis.

Pageof 11

Frequent Collaborators

13 joint publications

Saihong Ignatius Ou

8 joint publications

Zhaohui Liao Arter

4 joint publications

Stephen V Liu

4 joint publications

Ammar Sukari